Workflow
佐力药业(300181) - 2025年2月18日-2025年2月21日投资者关系活动记录表
300181ZUO LI YAO YE(300181)2025-02-21 13:44

Group 1: Sales and Market Strategy - The company has implemented a strategy of "price for volume" in regions where centralized procurement is executed, leading to sustained growth of selected products [1][2] - The company is expanding its outreach to the C-end market by collaborating with chain pharmacies and utilizing new media platforms like Xiaohongshu and Douyin for brand promotion [2] - The positioning of products is being upgraded, with the promotion of Wuling capsules evolving to address mild cognitive impairment (MCI) and enhancing brand awareness through consumer education [2] Group 2: Sales Team Development - The company currently employs over 600 sales personnel, with more than 100 in the OTC team, emphasizing the importance of talent in sales [3] - There is a focus on both external talent acquisition and internal training to enhance management capabilities and professional skills within the sales team [3] - The company aims to optimize collaboration among sales teams for various product lines to improve resource utilization [3] Group 3: Product Competitive Advantage - Wuling capsules are unique as a single-component formulation, ensuring high safety and patient compliance, and are recognized in 79 clinical guidelines and expert consensus [4][5] - The daily medication cost of Wuling capsules is reasonable, and they are classified as a basic national drug, which lowers out-of-pocket expenses for patients in centralized procurement areas [5] Group 4: Supply Chain and Quality Control - The company operates over 100 medicinal herb planting bases across the country, some of which are cooperative bases, and is advancing GAP planting base construction to ensure product quality [6] - Continuous optimization of the supply chain is being pursued to guarantee traceability from cultivation to consumption, aiming for steady economic growth [6] Group 5: Research and Development Focus - Recent R&D efforts include the innovation of Wuling series traditional Chinese medicine, with ongoing clinical trials and the development of new indications for existing products [7] - The company is actively participating in the establishment of national and provincial standards for traditional Chinese medicine formula granules, supporting sales growth [7] - Collaboration with renowned universities and research institutions is being enhanced to facilitate the application of new technologies [7] Group 6: Target Demographics for Wuling Capsules - Wuling capsules are suitable for a wide age range, addressing issues like insomnia and anxiety prevalent among students and the elderly [8] - The product's high safety profile and efficacy make it a preferred choice for students facing academic pressure [8]